A PHASE I STUDY OF THE SAFETY AND PHARMACOKINETICS OF RECOMBINANT HUMAN CD4-IMMUNOGLOBULIN G (RCD4-IGG) ADMINISTERED BY INTRAVENOUS BOLUS INJECTION IN COMBINATION WITH ORAL ZIDOVUDINE IN PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX: